期刊
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
卷 9, 期 6, 页码 727-740出版社
BENTHAM SCIENCE PUBL
DOI: 10.2174/187152710793237403
关键词
Tau; tauopathies; Alzheimer; frontotemporal dementia; kinase inhibitors; dementia; immunization
Tauopathies are neurodegenerative diseases characterized by insoluble hyperphosphorylated deposits of the microtubule-associated protein tau in the central nervous system. In these disorders, tau is believed to cause neurodegeneration and neuronal loss due to the loss of function of the normal protein, and/or the gain of toxic properties by generating multimeric species. The obstacles found in amyloid-based therapies in Alzheimer's disease, the most common tauopathy, have stimulated the search for alternative targets, including tau. In this article, we review the strategies aimed at reducing tau phosphorylation and aggregation as a target for drug intervention in tauopathies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据